@misc{ais_repository_984,
  title = {Cost Effectiveness Analysis of Rivaroxaban Compared to Warfarin and Aspirin for Stroke Prevention Atrial Fibrillation (SPAF) in the 
Indonesian healthcare setting},
  author = {None},
  year = {2022},
  publisher = {Fakultas Farmasi UGM},
  howpublished = {Repository AIS},
  note = {oai:ais:library-item:7763}
}